K
KKR
Acquirer counsel
Kirkland & Ellis
Alvaro MembrilleraPartner
Anna Van de moortelPartner
5 lawyers involved
Rainmaker
Loading page...
Kirkland & Ellis advises KKR on $2.8 billion acquisition of Karo Healthcare
Deal Overview
- Value
- $2.8bn
- Deal type
- M&A
- Structure
- Data in progress
- Status
- Data in progress
Advisors
ACQUIRER
Kirkland & Ellis Overview
- KKR is the acquirer of Karo Healthcare, a European consumer healthcare company, buying it from EQT. The deal follows a period in which Karo underwent rapid transformation, geographic expansion and strategic portfolio development.
- The transaction is an acquisition by KKR of Karo Healthcare from EQT. Financial terms, including valuation, stake size and financing, were not disclosed in the announcement.
- Signing has been announced, with closing expected in the coming months subject to customary conditions and regulatory approvals. The parties framed the deal as a milestone in Karo's development after its recent expansion and portfolio build-out.
K
Karo Healthcare
Seller counsel
White & Case LLP
Patrik ErbladPartner
14 lawyers involved
White & Case LLP Overview
- Karo Healthcare has been reshaped under EQT from a Nordics-focused specialty pharmaceutical company into a pan-European consumer healthcare platform.
- Karo generated EUR 530 million of revenue in 2024, and its fully digitised platform reaches consumers in more than 90 markets.
- The transaction is EQT's sale of portfolio company Karo Healthcare to KKR, transferring ownership of the business to the buyer.